Bionano Genomics Inc.

1.51-0.1100-6.79%Vol 5.44M1Y Perf -78.46%
Jun 27th, 2022 16:00 DELAYED
BID1.50 ASK1.51
Open1.62 Previous Close1.62
Pre-Market- After-Market1.51
 - -  - -%
Target Price
8.25 
Analyst Rating
Strong Buy 1.00
Potential %
446.36 
Finscreener Ranking
★★★★★     61.54
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★★     56.22
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★★+     63.92
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
4.97 
Earnings Rating
Strong Sell
Market Cap437.44M 
Earnings Date
3rd Aug 2022
Alpha0.08 Standard Deviation0.92
Beta2.17 

Today's Price Range

1.481.63

52W Range

1.168.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
2.03%
1 Month
-13.71%
3 Months
-36.82%
6 Months
-50.97%
1 Year
-78.46%
3 Years
-38.37%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BNGO1.51-0.1100-6.79
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Financial StrengthValueIndustryS&P 500US Markets
11.90
13.00
0.03
0.04
-243.80
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
18.00
-476.60
-451.50
-324.30
-
RevenueValueIndustryS&P 500US Markets
20.51M
0.07
15.70
13.09
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.08-0.11-37.50
Q04 2021-0.07-0.08-14.29
Q03 2021-0.06-0.07-16.67
Q02 2021-0.05-0.06-20.00
Q01 2021-0.05-0.050.00
Q04 2020-0.06-0.060.00
Q03 2020-0.06-0.08-33.33
Q02 2020-0.09-0.090.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.10-11.11Negative
9/2022 QR-0.10-11.11Negative
12/2022 FY-0.37-12.12Negative
12/2023 FY-0.37-8.82Negative
Next Report Date3rd Aug 2022
Estimated EPS Next Report-0.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume5.44M
Shares Outstanding289.70K
Shares Float289.52M
Trades Count11.57K
Dollar Volume8.27M
Avg. Volume6.59M
Avg. Weekly Volume7.33M
Avg. Monthly Volume6.01M
Avg. Quarterly Volume6.44M

Bionano Genomics Inc. (NASDAQ: BNGO) stock closed at 1.51 per share at the end of the most recent trading day (a -6.79% change compared to the prior day closing price) with a volume of 5.44M shares and market capitalization of 437.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 97 people. Bionano Genomics Inc. CEO is Mark Adamchak.

The one-year performance of Bionano Genomics Inc. stock is -78.46%, while year-to-date (YTD) performance is -49.5%. BNGO stock has a five-year performance of %. Its 52-week range is between 1.16 and 8.2, which gives BNGO stock a 52-week price range ratio of 4.97%

Bionano Genomics Inc. currently has a PE ratio of -4.90, a price-to-book (PB) ratio of 1.51, a price-to-sale (PS) ratio of 21.33, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -25.98%, a ROC of -26.31% and a ROE of -28.28%. The company’s profit margin is -%, its EBITDA margin is -451.50%, and its revenue ttm is $20.51 Million , which makes it $0.07 revenue per share.

Of the last four earnings reports from Bionano Genomics Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Bionano Genomics Inc.’s next earnings report date is 03rd Aug 2022.

The consensus rating of Wall Street analysts for Bionano Genomics Inc. is Strong Buy (1), with a target price of $8.25, which is +446.36% compared to the current price. The earnings rating for Bionano Genomics Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bionano Genomics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bionano Genomics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 26.03, ATR14 : 0.14, CCI20 : 28.35, Chaikin Money Flow : -0.02, MACD : -0.05, Money Flow Index : 64.47, ROC : -4.71, RSI : 52.65, STOCH (14,3) : 66.67, STOCH RSI : 1.00, UO : 44.44, Williams %R : -33.33), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bionano Genomics Inc. in the last 12-months were: Christopher Stewart (Option Excercise at a value of $46 200), David L. Barker (Buy at a value of $16 000), R. Erik Holmlin (Buy at a value of $20 037)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

CEO: Mark Adamchak

Telephone: +1 858 888-7600

Address: 9540 Towne Centre Drive, San Diego 92121, CA, US

Number of employees: 97

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

55%45%

Bearish Bullish

57%43%

TipRanks News for BNGO

Tue, 10 May 2022 21:29 GMT Bionano: The Bull Thesis Remains Intact, Says Analyst

- TipRanks. All rights reserved.

Fri, 08 Apr 2022 18:19 GMT Bionano: Important Catalysts Ahead Should Strengthen Value Proposition

- TipRanks. All rights reserved.

Mon, 07 Mar 2022 18:42 GMT Bionano Stock: 2022 an Inflection Year, Says Analyst

- TipRanks. All rights reserved.

Tue, 22 Feb 2022 18:05 GMT Bionano Genomics: Highly Speculative, High Upside Potential

- TipRanks. All rights reserved.

Tue, 15 Feb 2022 19:43 GMT Bionano Stock Retains Its Status

- TipRanks. All rights reserved.

Mon, 07 Feb 2022 18:14 GMT Bionano: OGM System on Track for Further Adoption

- TipRanks. All rights reserved.

Fri, 28 Jan 2022 21:23 GMT Bionano Genomics: Hard to Value, but Has Potential

- TipRanks. All rights reserved.

Thu, 20 Jan 2022 17:00 GMT Bionano Symposium 2022: What You Need to Know

- TipRanks. All rights reserved.

Thu, 20 Jan 2022 12:35 GMT BioNano Genomics (BNGO) Receives a Buy from Maxim Group

- TipRanks. All rights reserved.

News

Stocktwits